Technical Description
This technology is a heterocyclic derivative with strong binding affinity to Aβ1-42 aggregates and dual cholinesterase inhibition, and fluorescent properties for Alzheimer’s diagnosis and management.
Problems Addressed
- Fails Fluorescent Activity
- Complex Synthesis Process
- Lacks Efficient Binding
- Fails Diagnostic Utility
- Tedious Compound Production
Tech Features
- Enhanced Aβ Binding
- Dual Enzyme Inhibition
- Fluorescent Diagnostic Activity
- Efficient Synthesis Route
- Therapeutic Diagnostic Duality
Target Audience
- Pharmaceutical Companies
- Biotechnology Firms
- Diagnostic Reagent & Imaging Probe Manufacturers
- Academic & Research Institutions
Tech ID: P27-1469 TRL 3 Patent Status: Published Available For Exclusive and Non-exclusive License
